{"id":25183,"date":"2023-11-20T05:00:05","date_gmt":"2023-11-20T09:00:05","guid":{"rendered":"https:\/\/www.findtherapeutics.com\/?p=25183"},"modified":"2024-05-01T14:34:41","modified_gmt":"2024-05-01T18:34:41","slug":"participation-a-la-conference-dophtalmologie-btig","status":"publish","type":"post","link":"https:\/\/www.findtherapeutics.com\/fr\/participation-a-la-conference-dophtalmologie-btig\/","title":{"rendered":"Participation \u00e0 la BTIG Ophthalmology Conference"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\n
\"\"<\/figure>\n\n\n\n

<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Find Therapeutics participera \u00e0 une pr\u00e9sentation
lors de la BTIG Ophthalmology Conference<\/h4>\n

MONTR\u00c9AL, Canada, 20 novembre 2023 \u2013 Find Therapeutics Inc, soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de th\u00e9rapies innovantes pour les maladies auto-immunes, a annonc\u00e9 aujourd’hui que Philippe Douville, PDG de Find et Robert L. Glanzman, Chef de la direction m\u00e9dicale participeront \u00e0 une pr\u00e9sentation lors de la BTIG Ophthalmology Conference le lundi 27 novembre 2023 \u00e0 11h00 heure de l’Est (EDT).<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

CONTACT INVESTISSEUR
Argot Partners
Jonathan Nugent
205-566-3026
Find@argotpartners.com<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tCommuniqu\u00e9 de presse PDF<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\u00c0 propos de Find<\/h5>

Find Therapeutics se consacre au d\u00e9veloppement de th\u00e9rapies de nouvelle g\u00e9n\u00e9ration pour traiter les maladies inflammatoires auto-immunes. La soci\u00e9t\u00e9 a \u00e9t\u00e9 lanc\u00e9e en 2020 gr\u00e2ce aux investissements de CTI Life Sciences, adMare BioInnovations et Domain Therapeutics et \u00e0 une licence exclusive de l’Universit\u00e9 de Strasbourg relative \u00e0 une technologie et au savoir-faire connexe initialement d\u00e9velopp\u00e9s par le Dr Dominique Bagnard.
www.findtherapeutics.com<\/a><\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Philippe Douville, PDG de Find et Robert L. Glanzman, Chef de la direction m\u00e9dicale participeront \u00e0 une pr\u00e9sentation …<\/p>\n","protected":false},"author":1,"featured_media":25427,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_theme","format":"standard","meta":{"footnotes":""},"categories":[196],"tags":[],"table_tags":[],"class_list":["post-25183","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles"],"_links":{"self":[{"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/posts\/25183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/comments?post=25183"}],"version-history":[{"count":29,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/posts\/25183\/revisions"}],"predecessor-version":[{"id":25431,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/posts\/25183\/revisions\/25431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/media\/25427"}],"wp:attachment":[{"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/media?parent=25183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/categories?post=25183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/tags?post=25183"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/www.findtherapeutics.com\/fr\/wp-json\/wp\/v2\/table_tags?post=25183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}